COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,313 Articles (22,772 medRxiv, 8,541 bioRxiv)

Most recent first Previous |  Page 2733: Articles 27321-27330  | Next

Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran
Goshayeshi, L., Akbari Rad, M., Bergquist, R., Allahyari, A., MUMS Covid-19 Research Team, , Hoseini, B.
10.1101/2020.05.20.20108068 — Posted: 2020-05-23
A Rapid Review of the Asymptomatic Proportion of PCR-Confirmed SARS-CoV-2 Infections in Community Settings
Beale, S., Hayward, A., Shallcross, L., Aldridge, R. W., Fragaszy, E.
10.1101/2020.05.20.20108183 — Posted: 2020-05-23
COVID-19 receptor ACE2 is expressed in human conjunctival tissue, expecially in diseased conjunctival tissue
li, s., li, d., fang, j., liu, q., sun, x., xu, g., cao, w.
10.1101/2020.05.21.20109652 — Posted: 2020-05-23
Occupation and risk of COVID-19: prospective cohort study of 120,621 UK Biobank participants
Mutambudzi, M., Niedzwiedz, C. L., Macdonald, E. B., Leyland, A. H., Mair, F. S., Anderson, J. J., Celis-Morales, C. A., Cleland, J., Forbes, J., Gill, J. M., Hastie, C., Ho, F. K., Jani, B. D., Mackay, D. F., Nicholl, B. I., O'Donnell, C. A., Sattar, N. I., Welsh, P. I., Pell, J. P., Katikireddi, S. V., Demou, E.
10.1101/2020.05.22.20109892 — Posted: 2020-05-23 Discussion: Onsite
Risk Factors for COVID-19 versus non-COVID-19 related in-hospital and community deaths by Local Authority District in Great Britain
Leighton, S. P., Leighton, D. J., Herron, J., Upthegrove, R., Cavanagh, J., Gkoutos, G., Cullen, B., Mallikarjun, P. K.
10.1101/2020.05.21.20108936 — Posted: 2020-05-23
Changes in premature birth rates during the Danish nationwide COVID-19 lockdown: a nationwide register-based prevalence proportion study
Hedermann, G., Hedley, P. L., Baekvad-Hansen, M., Hjalgrim, H., Rostgaard, K., Poorisrisak, P., Breindahl, M., Melbye, M., Hougaard, D., Christiansen, M., Lausten-Thomsen, U.
10.1101/2020.05.22.20109793 — Posted: 2020-05-23 Discussion: Onsite
Biophysical modeling of the SARS-CoV-2 viral cycle reveals ideal antiviral targets
Castle, B. T., Dock, C., Hemmat, M., Kline, S., Tignanelli, C., Rajasingham, R., Masopust, D., Provenzano, P., Langlois, R., Schacker, T., Haase, A., Odde, D. J.
10.1101/2020.05.22.111237 — Posted: 2020-05-23
Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease
Suarez-Farinas, M., Tokuyama, M., Wei, G., Huang, R., Livanos, A., Jha, D., Levescot, A., Kosoy, R., Irizar, H., Cording, S., Wang, W., Ungaro, R., Di Narzo, A., Martinez, G., Suprun, M., Corley, M. J., Stojmirovic, A., Houten, S., Curran, M., Brodmerkel, C., Perrigoue, J., Friedman, J. R., Hao, K., Schadt, E. E., Zhu, J., Ko, H. M., Cho, J., Dubinsky, M. C., Sands, B. E., Ndhlovu, L., Cerf-Bensusan, N., Kasarskis, A., Colombel, J.-F., Harpaz, N., Argmann, C., Mehandru, S.
10.1101/2020.05.21.109124 — Posted: 2020-05-23 Discussion: Onsite | Offsite
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions
Mathew, D., Giles, J. R., Baxter, A. E., Greenplate, A. R., Wu, J. E., Alanio, C., Oldridge, D. A., Kuri-Cervantes, L., Pampena, M. B., D'Andrea, K., Manne, S., Chen, Z., Huang, Y. J., Reilly, J. P., Weisman, A. R., Ittner, C. A. G., Kuthuru, O., Dougherty, J., Nzingha, K., Han, N., Kim, J., Pattekar, A., Goodwin, E. C., Anderson, E. M., Weirick, M. E., Gouma, S., Arevalo, C. P., Bolton, M. J., Chen, F., Lacey, S. F., Hensley, S. E., Apostolidis, S., Huang, A. C., Vella, L. A., UPenn COVID Processing Unit, , Betts, M. R., Meyer, N. J., Wherry, E. J.
10.1101/2020.05.20.106401 — Posted: 2020-05-23 Discussion: Onsite | Offsite
The emergence of SARS-CoV-2 in Europe and the US
Worobey, M., Pekar, J., Larsen, B. B., Nelson, M. I., Hill, V., Joy, J. B., Rambaut, A., Suchard, M. A., Wertheim, J. O., Lemey, P.
10.1101/2020.05.21.109322 — Posted: 2020-05-23 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).